---
title: "484 Biotech Investors (Nov 2026): Top 10 by Fund Activity"
last_updated: "2026-11-09"
rows: "484"
free_rows: "25"
source: "SEC Form D filings and our own research"
canonical: "https://theinvestordatabase.com/lists/biotech-investors/"
---

# 484 biotech investors

We list 484 biotech investors as of November 2026: 302 have an SEC filing on file and 182 were checked on the firm's own website or an official register, and the list was last checked on 9 Nov 2026. The states with the most are California (108), Massachusetts (37) and New York (29).

- 484 investors
- 251 with a fund filing or dated deal in the last 12 months
- $80M median fund size on file (SEC Form D, 203 firms)
- 2,311 named decision-makers on file

## First 25 of 484 biotech investors

| Investor | Type | HQ | Stages (our research) | Focus (our research) | Latest fund or deal | Fund size | Checked | Profile |
|---|---|---|---|---|---|---|---|---|
| Cambridge Innovation Capital | VC firm | Cambridge, United Kingdom | Seed, Series A, Growth | Biotech, Healthtech, AI, Fintech | New fund, Oct 2026 | £600M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/cambridge-innovation-capital/ |
| Vida Ventures | VC firm | Los Angeles, CA |  | Biotech, Healthtech | New fund, Sep 2026 | $750M (SEC Form D, 2021) | 2026-11-04 | https://theinvestordatabase.com/investors/vida-ventures/ |
| ARCH Venture Partners | VC firm | Chicago, IL | Pre-seed, Seed | Biotech, Healthtech, Deep Tech | New fund, Aug 2026 | $3.0B (SEC Form D, 2024) | 2026-11-04 | https://theinvestordatabase.com/investors/arch-venture-partners/ |
| TCGX | VC firm | Palo Alto, CA |  | Biotech, Healthtech | New fund, Oct 2026 | $600M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/tcgx/ |
| SR One | VC firm | Wayne, PA |  | Biotech, Healthtech | New fund, Sep 2026 | $600M (SEC Form D, 2024) | 2026-11-04 | https://theinvestordatabase.com/investors/sr-one/ |
| Hatteras Venture Partners | VC firm | Durham, NC | Seed | Biotech, Healthtech, Medtech | New fund, Oct 2026 | $250M (SEC Form D, 2023) | 2026-11-04 | https://theinvestordatabase.com/investors/hatteras-venture-partners/ |
| Thirdrockventures | VC firm | Boston, MA | Pre-seed, Seed | Biotech, Healthtech, Medtech | New fund, Jun 2026 | $1.1B (SEC Form D, 2022) | 2026-11-04 | https://theinvestordatabase.com/investors/thirdrockventures/ |
| First In Ventures | VC firm | Hobe Sound, FL | Pre-seed, Seed | Biotech, Healthtech, AI, Climate Tech | New fund, Sep 2026 | $22M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/first-in-ventures/ |
| M Ventures | Corporate VC | Amsterdam, Netherlands |  | Biotech, Healthtech, AI, Deep Tech | Portfolio news, Oct 2026 | $27M (SEC Form ADV) | 2026-11-04 | https://theinvestordatabase.com/investors/m-ventures/ |
| AMR Action Fund | VC firm | Boston, MA |  | Biotech, Healthtech, Media, Medtech | Portfolio news, Aug 2026 | $977M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/amr-action-fund/ |
| Lionheart Ventures | VC firm | San Francisco, CA |  | Biotech, Healthtech, Climate Tech, AI | New fund, Aug 2026 | $21M (SEC Form D, 2021) | 2026-11-04 | https://theinvestordatabase.com/investors/lionheart-ventures/ |
| Longitude Venture Partners | VC firm | Menlo Park, CA | Growth | Biotech, Healthtech, Medtech | New deal, Jun 2026 | $600M (SEC Form D, 2022) | 2026-11-05 | https://theinvestordatabase.com/investors/longitude-venture-partners/ |
| Sofinnova | VC firm | Menlo Park, CA |  | Biotech, Healthtech | New fund, Jun 2026 | $550M (SEC Form D, 2024) | 2026-11-04 | https://theinvestordatabase.com/investors/sofinnova/ |
| Future Ventures | VC firm | Los Altos, CA | Seed | Biotech, Healthtech, AI, Energy | New fund, Oct 2026 | $200M (SEC Form D, 2021) | 2026-11-04 | https://theinvestordatabase.com/investors/future-ventures/ |
| Claret Capital Partners | Venture debt | London, United Kingdom | Series B, Growth, Late stage | Biotech, Healthtech, Climate Tech, SaaS | New deal, Oct 2026 | €575M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/claret-capital-partners/ |
| HBM Partners | Fund manager | Zug, Switzerland | Series A, Series B, Growth, Late stage | Biotech, Healthtech, Medtech | Portfolio news, Oct 2026 | $2.8B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/hbm-partners-ag/ |
| Breakout Ventures | VC firm | San Francisco, CA | Seed | Biotech, AI, Healthtech, Industrial Tech | New deal, Jun 2026 | $112M (SEC Form D, 2021) | 2026-11-04 | https://theinvestordatabase.com/investors/breakout-ventures/ |
| Felicis | VC firm | Menlo Park, CA | Seed, Series A | Biotech, AI, Developer Tools, Healthtech | New deal, Oct 2026 | $900M (SEC Form D, 2025) | 2026-11-05 | https://theinvestordatabase.com/investors/felicis/ |
| Digitalis Ventures | VC firm | New York, NY | Seed | Biotech, Healthtech, Medtech | Portfolio news, Nov 2026 | $862M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/digitalis-ventures/ |
| Artis | VC firm | San Francisco, CA |  | Biotech, Healthtech, AI, Deep Tech | New fund, Jun 2026 | $300M (SEC Form D, 2022) | 2026-11-04 | https://theinvestordatabase.com/investors/artis/ |
| Andera Partners | Fund manager | Paris, France | Seed, Series A, Series B, Growth | Biotech, Medtech, Healthtech, Generalist | Portfolio news, Sep 2026 | €6.0B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/andera-partners/ |
| Truffle Capital | VC firm | Paris, France |  | Biotech, Healthtech, Medtech, Fintech | Portfolio news, Oct 2026 | €500M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/truffle-capital/ |
| Cancer Focus Fund | VC firm | Shreveport, LA |  | Biotech, Healthtech | New fund, May 2026 | $148M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/big-ventures/ |
| Fountain Healthcare Partners | VC firm | Dublin, Ireland | Seed | Biotech, Healthtech, Medtech | Portfolio news, Oct 2026 | €425M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/fountain-healthcare-partners/ |
| BGF | VC firm | United Kingdom | Seed, Series A, Series B, Growth | Biotech, Healthtech, Edtech, Developer Tools | Portfolio news, Oct 2026 | £3.0B (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/bgf/ |

You are seeing 25 of 484. The full list adds 459 more investors and 2,311 named decision-makers.

Get all 484 investors and 2,311 named contacts, $297, one-time: https://theinvestordatabase.com/buy/bundle
This page: https://theinvestordatabase.com/lists/biotech-investors/

## Method and limits
- Source: 302 of the 484 rows carry an SEC filing (Form D or Form ADV). 476 of the 484 have a website we checked; the other 8 rest on the filing or register entry alone. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule: Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states biotech and life sciences as a focus on its own site, or we observed it in the firm's portfolio.
- Order: Activity score out of 100: recency of the latest fund filing or dated deal (40: within 3 months 40, 6 months 30, 12 months 20, 24 months 10), share of the observed portfolio in this sector (30; 15 when the sector is stated only), size of the fund on file on a log scale (20) and completeness of the public record (10). It is a measure of activity and fit, not of quality or returns.
- Fill rates: Of 484 rows: stage 385, sector 484, fund size 343, website 476. In the paid file: named decision-makers on 442 rows, firm email on 218, LinkedIn page on 282, check size on 89.

## Questions
### How many biotech investors are there?
We list 484 as of November 2026. 251 of the 484 have a fund filing or a dated deal in the last 12 months. By region: United States (302), United Kingdom (92) and Europe (89).

### Which biotech investors raised a new fund in the last 12 months?
115 of the 484 have a fund filing dated in the last 12 months. The most recent on this list are Hyve Ventures (Nov 2026), Future Ventures (Oct 2026) and Draper Associates (Oct 2026).

### What is the typical fund size of biotech investors?
The median fund size on file for this list is $80M, across the 203 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 281 do not disclose a size there.

### Which stage do most biotech investors back?
Of the 385 with a stage on file, seed (300), Series A (153) and pre-seed (148). A firm can back more than one stage, and 99 rows have no stage on file yet.

### Where does the data on biotech investors come from and how often is it updated?
302 of the 484 rows have an SEC filing on file (Form D or Form ADV) and 182 were checked on the firm's own website or an official register. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 9 Nov 2026 at the latest. The whole file is re-verified twice a year.

### Can I download the list of biotech investors as a spreadsheet?
Yes. The file holds all 484 rows in Excel and CSV, with 2,311 named decision-makers and 218 firm emails, for $297 one-time as part of Global Bundle. 25 rows are free on this page.